HBI Deals+Insights / News

Thyrocare IPO subscribed 73 times over

Indian healthcare equities are still highly prized if the INR 480 crore (US$72m) IPO of the lab group, Thyrocare, is to be believed. The available shares were oversubscribed 73 times.

We would welcome your thoughts on this story. Email your views to Claude Risner or call 0207 183 3779.